Review of drug studies ordered
16125
The Food and Drug Administration yesterday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
169384
The US Food and Drug Administration is pushing for an expanded review of MDS Pharma&#39;s generic drug studies at its Montreal laboratories, and has requested a meeting with the company to discuss its concerns.
622142
LEADING medical journal editors and lawmakers have rightfully focused a spotlight on how well the Food and Drug Administration monitors the safety of drugs after they are approved.
458929
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc and Schering-Plough's cholesterol medicine Vytorin  following the drug's failure to work better than a generic drug  in a study of plaque build-up in neck arteries.
733605
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc  and Schering-Plough's  cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
404075
New evidence is raising questions about the tests used to prescribe the breast cancer drug Herceptin, which was initially seen as a model for tailored medicine.
131481
Nov. 5, 2004 -- FDA officials announced Friday that they will launch a review of the agency&#39;s drug monitoring policies in the wake of recent high-profile safety concerns about widely used drugs, including antidepressants and Vioxx.
6886
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with anemia drugs sold by Amgen Inc and Johnson & Johnson.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
321830
The FDA grants a speedy review for Millennium's lead drug.
402115
Two drugs provide good results in preliminary trials.
93812
The results from the new clinical trial could increase the chances that the Food and Drug Administration will approve the drug for that use.
721361
A vast majority of patients and doctors would surely agree that pharmaceutical companies ought to reveal the results of clinical trials that suggest that their drugs don&#39;t work or may even be harmful.
89594
Description: A Bush Administration task force releases a report that finds importing drugs from countries with price-controls offers little savings and introduces safety concerns.
552158
It can be incredibly difficult for patients to ferret out studies of experimental drugs that offer hope to threat their disease. There is no comprehensive database of ongoing clinical trials, but specialists offer advice for the search:
535175
BioSante releases more info on the pivotal studies for its lead drug.